An article from
News roundup
Hundreds of executives and investors are pushing for Rick Pazdur to be the next FDA commissioner. Elsewhere, Alumis is discarding a once-highly touted immune drug.
Published May 15, 2026
Getty Images
Hundreds of executives and investors are pushing for Rick Pazdur to be the next FDA commissioner. Elsewhere, Takeda detailed its latest restructuring and Alumis is discarding a once-highly touted immune drug.
An article from
News roundup
Hundreds of executives and investors are pushing for Rick Pazdur to be the next FDA commissioner. Elsewhere, Alumis is discarding a once-highly touted immune drug.
Published May 15, 2026
Getty Images

With the FDA now rudderless following the revelation that commissioner Marty Makary, M.D., is stepping down, voices across…

Alzheimer's drug rollout letdown, a China-based heart drug startup, and more biotech news from The Readout

They called for stability and predictability at the agency at Axios' Future of Health summit.

The U.S. Food and Drug Administration is shuffling its top drug and biologics regulators, days after the departure of former…

With the ink barely dry on outgoing commissioner Marty Makary’s resignation, another top regulator may be heading for the exit at…

A Duchenne therapy lawsuit, FDA Commissioner Marty Makary’s White House troubles, and other news from The Readout